• Facebook
  • Instagram
  • Instagram
  • YouTube
  • Blog
  • Contact Us
  • HealthSupply Portal
  • MyOrders
PFSCM
  • About Us
    • Products
    • Sustainability
    • Quality
    • Our Global Community
  • Health Areas
    • Antimicrobial Resistance
    • Genomic Surveillance
    • Medical imaging
    • HIV/AIDS
    • Malaria
    • Tuberculosis
  • Services
    • Illumina Global Health Access Initiative
    • Category management
    • Channel management
    • Project-based procurement
    • 4PL Services
    • Procurement Services
    • Digital Supply Chain
  • Work With Us
    • Requests for Proposals
    • Career Opportunities
  • News
    • Resources
    • PFSCM Newsletters
Select Page
Why CD4 Still Counts: understanding the supply chain implications of recent market changes

Why CD4 Still Counts: understanding the supply chain implications of recent market changes

by PFSCM | Mar 26, 2024 | CD4, HIV

By Tim Meehan | March 2024 The CD4 diagnostic landscape has undergone significant changes in recent years, with key testing platforms being discontinued. This has disrupted the supply chain, making it more difficult for countries to secure CD4 stock, and potentially...

Related Posts

[related taxonomy=news_category count=3] [field title-link] [/related]
  • Accessibility
  • Privacy
  • Terms of Use
  • Intranet